Displaying 1 - 6 of 6 for Cancer - Colon/Rectal
  • AMC-088 Study (H-39190)
    • This randomized phase III trial studies imiquimod or fluorouracil to see how well they work compared to observation in treating patients with high-grade anal squamous skin lesions who are human immunodeficiency virus (HIV)-positive.
  • Biospecimen Banking (H-37203)
    • This study obtains samples from HIV-positive and negative patients with HPV-related cancers of the oropharynx, cervix and anus.
  • PROSPECT Study (H-32928)
    • The purpose of this study is to investigate how well chemotherapy alone compared to chemotherapy plus radiation therapy works in treating patients with rectal cancer undergoing surgery.
  • Stage IV Colorectal Carcinoma (H-38989)
    • In this study, participants with MSI-H or dMMR advanced colorectal carcinoma will be randomly assigned to receive either pembrolizumab or the investigator's choice of chemotherapy regimens for the treatment of advanced colorectal carcinoma.
  • Surgery or Non-Surgical Management in Treating Patients With Intra-Abdominal Cancer and Bowel Obstruction (H-38885)
    • The purpose of this clinical trial is to study surgery or non-surgical management in treating patients with intra-abdominal cancer and bowel obstruction.
  • TACTASOM Study (H-35425)
    • This study uses special immune system cells called tumor-associated antigen (TAA)-specific cytotoxic T lymphocytes, a new experimental therapy to treat patients with a solid tumor which has come back or has not gone away after treatment.